Insider Buying: VBI Vaccines Inc. (NASDAQ:VBIV)

VBI Vaccinesstock is being impacted by recent insider buying, in which the Chief Medical Officer of the company Diaz-Mitoma Francisco purchases shares. On June 27, 2019 he purchased 8,000 shares of VBI Vaccines Inc. (NASDAQ:VBIV) of worth $77,500 as per SEC form 4.

The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the VBIV is 12.00%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the VBIV is 55.58%.

Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that VBIV. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the VBI Vaccines Inc. (NASDAQ:VBIV) is 23.16%.

Institutional ownership is the amount of a VBI Vaccines Inc. (NASDAQ:VBIV)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it.

U.S traded VBI Vaccines Inc. (NASDAQ:VBIV) stock ticked up 6.36% on Friday and when day-trade ended the stock finally concluded at $1.17 and number of shares that changed hands during the day are 10.39 Million. The number of shares VBIV stock currently held by all its shareholders are 97.66 and floated shares, the number of shares are available for trading in an open market on last trading day are 50.92. The average volume of shares for 3 months is 1699.75 and VBIV stock value has moved between $0.58 – 3 in last one year.

The VBI Vaccines Inc. (NASDAQ:VBIV)’s latest earnings date is 07/31/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The stock has gained -26.88% in 2019 to date.

U.S. traded shares of VBI Vaccines Inc. (NASDAQ:VBIV)’s monthly stock performance is -40.91%, the quarterly performance is -37.43%, the half year performance is calculated as -19.31%. The yearly performance of VBIV is -59.09%.

The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The VBI Vaccines Inc. (NASDAQ:VBIV) weekly volatility is measured as 20.31% and monthly volatility measured as 15.71%.

Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets.

The price to sales ratio is 32.31, and price to book ratio is 1.32.

Analysts mean target price for VBI Vaccines Inc. (NASDAQ:VBIV) is $8.25 while analysts mean recommendation is 1.50. The current share price indicates that stock is -61.00% away from its one year high and is moving 103.48% ahead of its 52-week low. VBIV’s distance from 20 day simple moving average is -18.10% and distance from 50-Day simple moving average is -33.93%.

Leave a Reply